Nathan Higginson-Scott
Chief Tech/Sci/R&D Officer presso PANDION THERAPEUTICS, INC.
Profilo
Nathan Higginson-Scott has worked as a Vice President-Research at Pandion Therapeutics, Inc. since 2020.
Posizioni attive di Nathan Higginson-Scott
| Società | Posizione | Inizio |
|---|---|---|
| PANDION THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/08/2020 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Pandion Therapeutics, Inc.
 Pandion Therapeutics, Inc. BiotechnologyHealth Technology Pandion Therapeutics, Inc. is a clinical stage biopharmaceutical company. It develops Therapeutic Autoimmune reguLatOry proteiN (TALON) drug design and discovery platform, which employ a modular approach to create a pipeline of product candidates using immunomodulatory effector modules that act at known control nodes within the immune network. The company was founded by Dr. Joanne Viney on September 19, 2016 and is headquartered in Watertown, MA. | Health Technology |
- Borsa valori
- Insiders
- Nathan Higginson-Scott
